Last updated on August 2020

Study of the Effects of Fabrazyme Treatment on Lactation and Infants


Brief description of study

The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months

Detailed Study Description

NOTE: Estimated Enrollment: 10 mothers and up to 10 infants

Clinical Study Identifier: NCT00230607

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.